BRIEF-Beacon Biosignals Announces Partnership With Harmony Biosciences

Reuters2025-12-16

BRIEF-Beacon Biosignals Announces Partnership With <a href="https://laohu8.com/S/HRMY">Harmony Biosciences</a>

Dec 16 (Reuters) - Harmony Biosciences Holdings Inc HRMY.O:

BEACON BIOSIGNALS ANNOUNCES PARTNERSHIP WITH HARMONY BIOSCIENCES TO ADVANCE OBJECTIVE CLINICAL ENDPOINTS IN HYPERSOMNIA CONDITIONS THROUGH QUANTITATIVE EEG

Source text: ID:nGNX5wlMZf

Further company coverage: HRMY.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2591412986?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-16 19:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2591412986","market":"nz","top_or_hot":-1,"title":"BRIEF-Beacon Biosignals Announces Partnership With Harmony Biosciences","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Beacon Biosignals Announces Partnership With <a href=\"https://laohu8.com/S/HRMY\">Harmony Biosciences</a> </title></head><body><p><span>Dec 16 (Reuters)</span><span> - </span>Harmony Biosciences Holdings Inc <span>HRMY.O</span>:</p><ul><li><p>BEACON BIOSIGNALS ANNOUNCES PARTNERSHIP WITH HARMONY BIOSCIENCES TO ADVANCE OBJECTIVE CLINICAL ENDPOINTS IN HYPERSOMNIA CONDITIONS THROUGH QUANTITATIVE EEG</p></li></ul><p>Source text: <span>ID:nGNX5wlMZf</span></p><p>Further company coverage: <span>HRMY.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Beacon Biosignals Announces Partnership With Harmony Biosciences</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Beacon Biosignals Announces Partnership With Harmony Biosciences\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-16 19:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Beacon Biosignals Announces Partnership With <a href=\"https://laohu8.com/S/HRMY\">Harmony Biosciences</a> </title></head><body><p><span>Dec 16 (Reuters)</span><span> - </span>Harmony Biosciences Holdings Inc <span>HRMY.O</span>:</p><ul><li><p>BEACON BIOSIGNALS ANNOUNCES PARTNERSHIP WITH HARMONY BIOSCIENCES TO ADVANCE OBJECTIVE CLINICAL ENDPOINTS IN HYPERSOMNIA CONDITIONS THROUGH QUANTITATIVE EEG</p></li></ul><p>Source text: <span>ID:nGNX5wlMZf</span></p><p>Further company coverage: <span>HRMY.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nTUA8NLJ53:1","article_id":"2591412986","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2591412986","pubTimestamp":1765884685,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Beacon Biosignals Announces Partnership With Harmony Biosciences Dec 16 (Reuters) - Harmony Biosciences Holdings Inc HRMY.O:BEACON BIOSIGNALS ANNOUNCES PARTNERSHIP WITH HARMONY BIOSCIENCES TO AD","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","HRMY":"Harmony Biosciences Holdings, Inc."},"translate_title":"BRIEF-Beacon Biosignals宣布与Harmony Biosciences合作","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HRMY":0.9},"content_text":"BRIEF-Beacon Biosignals Announces Partnership With Harmony Biosciences Dec 16 (Reuters) - Harmony Biosciences Holdings Inc HRMY.O:BEACON BIOSIGNALS ANNOUNCES PARTNERSHIP WITH HARMONY BIOSCIENCES TO ADVANCE OBJECTIVE CLINICAL ENDPOINTS IN HYPERSOMNIA CONDITIONS THROUGH QUANTITATIVE EEGSource text: ID:nGNX5wlMZfFurther company coverage: HRMY.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2591412986","isCrawlerRequest":true}